Manufacturers’ Monthly's first Manufacturing Leaders of Innovation event was hosted on 21 July 2016 at Trajan's Global Corporate Headquarters in Melbourne, Australia, and supported by Autodesk.
From Manufacturers' Monthly:
Innovation might be a word some are sick of, but it remains essential for success. Melbourne-based manufacturer Trajan Scientific and Medical shared a few insights into what it involves for them.
Read the full article at Manufacturers' Monthly: How to avoid making buggy whips
Photo: Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical speaking at Manufacturing Leaders of Innovation event.
Trajan Scientific and Medical’s hemaPEN® microsampling technology has been developed with extensive consultation and evaluation by leading analytical laboratories, clinicians and healthcare professionals.
This month, Trajan presents an exclusive interview with researcher Dr Michele Protti of Pharmaco-Toxicological Analysis, Bologna, Italy, on the future of microsampling and the critical role hemaPEN can play when used in therapeutic drug monitoring for optimal therapy personalization.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.